Since the Innovative Medicines Initiative (IMI) began in 2008, it has funded many successful programmes to improve healthcare across the European Union (EU), and the European Medical Information Framework (EMIF) has been no exception. The accomplishments made through EMIF—especially in the areas of dementia, metabolic disorders, and data harmonization— have produced a proven model for collaboration and data management in medical research. In doing so, “EMIF is allowing research to happen at a speed and scale that was previously not possible,” says Bart Vannieuwenhuyse, Co-Coordinator of the overall EMIF project and Senior Director at Janssen Clinical Innovation – Patient Data for Research (JCI-PDR).

Click here to read the full article.